Palbociclib Isethionate | m-entrepreneurship.com

Product Name :
Palbociclib Isethionate

Search keywords :
Palbociclib

drugId :
null

Target Vo:
Cyclin-dependent kinase 6

Target Vo Short Name :
CDK6

Moa_Name:
Cyclin-dependent kinase 6 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Alliance Foundation Trials Llc

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Carcinoma, Intraductal, Noninfiltrating

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Rituximab (anti-CD20) Technical Information
Osocimab Purity & Documentation
Cleaved PARP Antibody: Cleaved PARP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 89 kDa, targeting to Cleaved PARP. It can be used for WB,ICC,IP,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts